膀癌中的核糖体S6激酶4的表达及其与临床病理特征的相关性
Zhenzhen Li1,2, Gongchen Wang1,2, Siyu Tan2
1Yan'an Medical College, Yan'an University, Yan'an, China.
Frontiers in oncology
|March 9, 2026
概括
核糖体S6激酶4 (RSK4) 在膀癌中过度表达,与晚期疾病和生存率差相关. 这一发现表明RSK4是改善患者治疗结果的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 泌尿器细胞癌的癌症.
背景情况:
- 膀癌管理面临挑战,因为治疗目标有限,治疗反应多样.
- 核糖体S6激酶4 (RSK4) 是几种癌症的致癌驱动因素,但其在膀癌中的作用尚不清楚.
研究的目的:
- 在膀癌中调查Ribosomal S6激酶4 (RSK4) 蛋白质表达.
- 评估RSK4表达与临床病理特征和患者结局之间的关联.
主要方法:
- 用免疫组织化学分析了143个膀癌样本中的RSK4表达.
- 统计分析评估了RSK4水平,临床病理参数和整体存活率之间的相关性.
主要成果:
- 在65.7%的瘤样本中,RSK4的表达过度,与正常泌尿器皮相比 (P < 0.0001).
- 升高的RSK4表达与晚期疾病标志物显著相关:肌肉自身入侵,高瘤级别,晚期TNM阶段,淋巴结和远程转移.
- 多变量分析确定RSK4是减少整体存活时间的独立预测因子 (HR = 2.34,P < 0.001).
结论:
- 过度表达RSK4是预测膀泌尿腺癌预后不佳的关键因素.
- RSK4增强了膀癌细胞的入侵和转移.
- RSK4代表了改善膀癌临床结果的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K


